Subjects: MASTECTOMIA, MÉTODO DUPLO-CEGO, NEOPLASIAS MAMÁRIAS, COMPLICAÇÕES PÓS-OPERATÓRIAS
ABNT
GRIGIO, Thiago Ramos et al. Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1688. Acesso em: 23 ago. 2024.APA
Grigio, T. R., Sousa, A. M., Magalhaes, G. G. N., Ashmawi, H. A., & Vieira, J. E. (2020). Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial. Clinics, 75. doi:10.6061/clinics/2020/e1688NLM
Grigio TR, Sousa AM, Magalhaes GGN, Ashmawi HA, Vieira JE. Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial [Internet]. Clinics. 2020 ; 75[citado 2024 ago. 23 ] Available from: https://doi.org/10.6061/clinics/2020/e1688Vancouver
Grigio TR, Sousa AM, Magalhaes GGN, Ashmawi HA, Vieira JE. Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial [Internet]. Clinics. 2020 ; 75[citado 2024 ago. 23 ] Available from: https://doi.org/10.6061/clinics/2020/e1688